SNDX EBITDA Growth
Syndax Pharmaceuticals Inc · EBITDA Growth
SNDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported59.04%period ending
SNDX TTM EBITDA YoY % (-267.82% → 59.04%)
Year-over-year change
High-resolution chart · PNG
SNDX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 59.0397% | |
| 51.3869% | |
| 28.4767% | |
| -0.5538% | |
| -25.1458% | |
| -39.0447% | |
| -50.0531% | |
| -68.7874% | |
| -66.5059% | |
| -59.475% | |
| -43.0819% | |
| -1,526.7203% | |
| -5,653.9783% | |
| -963.7635% | |
| -643.8809% | |
| 87.878% | |
| 103.206% | |
| 120.9949% | |
| 137.9564% | |
| -37.8477% | |
| -54.2181% | |
| -47.8619% | |
| -27.4021% | |
| -6.4386% | |
| 12.1798% | |
| 19.3047% | |
| 26.1291% | |
| 19.9953% | |
| 10.6987% | |
| -1.7452% | |
| -21.4353% | |
| -42.5679% | |
| -38.1973% | |
| -42.3446% | |
| -41.9921% | |
| -35.7272% | |
| -79.2841% | |
| -84.3592% | |
| -100.7915% | |
| -114.3863% | |
| -45.7164% | |
| -20.3728% | |
| -1.9374% | |
| 12.393% | |
| -31.8411% | |
| -92.9843% | |
| -149.0886% | |
| -267.8214% |